Within every industry, there's an Apple or a GE, says Luke Timmerman at Xconomy"anchors" or "models of success" that other companies in that industry look up to. In biotech, that role has been filled by companies like Genentech and Genzyme, Timmerman adds, but because of buyouts and mergers in almost every regional cluster, the industry is losing its anchors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.